152
Participants
Start Date
October 31, 2016
Primary Completion Date
December 31, 2018
Study Completion Date
January 31, 2019
SEL-212
SEL-212, biologic
SEL-037
SEL-037, biologic
SVP-rapamycin (SEL-110)
SVP-rapamycin, biologic
Altoona Center for Clinical Research, Duncansville
Triad Clinical Trials LLC, Greensboro
Omega Research Consultants LLC, DeBary
Compass Research LLC, Orlando
Clinical Research of West Florida, Clearwater
L-MARC, Louisville
New Horizons Clinical Research, Cincinnati
Advanced Clinical Research, Boise
Advanced Clinical Research, West Jordan
Tri West Research Associates LLC, El Cajon
Irvine Center for Clinical Research Inc., Irvine
Anaheim Clinical Trials, Anaheim
East-West Medical Research Institute, Honolulu
Selecta Biosciences, Inc.
INDUSTRY